|
|
|
Volumn 33, Issue 3, 2006, Pages 397-401
|
|
Clinical experience with a new synthetic retinoid, tamibarotene (Am-80) for relapsed or refractory acute promyelocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZOIC ACID DERIVATIVE;
RETINOID;
TAMIBAROTENE;
TETRALIN DERIVATIVE;
CELL DIFFERENTIATION;
CHEMISTRY;
DRUG ADMINISTRATION;
DRUG EFFECT;
FEMALE;
HUMAN;
MALE;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PILOT STUDY;
PROMYELOCYTIC LEUKEMIA;
RECURRENT DISEASE;
REMISSION;
REVIEW;
BENZOATES;
CELL DIFFERENTIATION;
CLINICAL TRIALS, PHASE II;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
MALE;
PILOT PROJECTS;
RECURRENCE;
REMISSION INDUCTION;
RETINOIDS;
TETRAHYDRONAPHTHALENES;
|
|
EID: 33645396955
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (23)
|
